Debbie Orcutt
patient
Debbie Orcutt, diagnosed with aggressive pancreatic cancer in 2024, participated in a clinical trial for an experimental drug, daraxonrasib, after being given limited treatment options. Her tumors shrank by 64%, raising hopes for innovative cancer therapies.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Greece:
Debbie Orcutt was diagnosed with pancreatic cancer and decided to participate in a clinical trial for an experimental drug.
7
Andrew Nixon
Brian Wolpin
Lei Zheng
Kevan Shokat
Mark Goldsmith
Anna Berkenblit
Pranati Perati
Marty Makary
Kathimerini: Πειραματικό χάπι γεννά ελπίδες για έναν από τους πιο θανατηφόρους καρκίνους